Laser Capture Microdissection Market Size, Share & Industry Analysis By Type (Hardware [Instruments {Ultraviolet LCM, Infrared LCM, Immunofluorescence LCM, and Others} and Consumables] and Software & Services), By Application (Research & Development, Diagnostics, and Others), By End User (Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnological Companies, and Others), and Regional Forecast, 2026-2034

The global laser capture microdissection market size was valued at USD 279.6 million in 2025 and is projected to grow from USD 299.9 million in 2026 to USD 552.0 million by 2034, exhibiting a CAGR of 7.9% during the forecast period.

Laser capture microdissection is a method used to isolate and collect specific cells using a laser from a microscopic slide for detailed analysis. The increasing prevalence of various types of cancer, such as breast cancer, lung cancer, and others, is resulting in an increasing patient pool in clinical facilities. The growing patient pool is further boosting demand for tumor microenvironment profiling and other applications, thereby supporting the adoption rate of these laser capture microdissection devices in the market.

• For instance, according to the 2025 data published by the American Cancer Society (ACS), about 226,650 new cases of lung cancer were reported in the U.S.

Furthermore, the growing investments in tissue-based research are also a major factor supporting the increasing demand for these procedures in the market. This, coupled with rising focus toward integration of technological advancements in these products, is driving the focus of prominent players, including Thermo Fisher Scientific Inc. and Danaher Corporation, among others, and is expected to support the global market growth.

Market Dynamics

Market Drivers

Increasing Prevalence of Cancer to Support Market Growth

The rising prevalence of various types of cancer, such as prostate cancer, lung cancer, and others, which require precise isolation of specific cells from varied tissue samples and is supporting the growing demand for biomarker discovery, molecular pathology, and others, subsequently boosting the adoption rate for laser capture microdissection products in the market.

• For instance, according to statistics published by the World Cancer Research Fund (WCRF), approximately 1.5 million new cases of prostate cancer were reported globally in 2022.

Moreover, the benefits of this technique, such as early disease detection and targeted therapy development, are also supporting the rising adoption of tissue-based research among researchers, further boosting the demand for laser capture microdissection products globally. Therefore, the factors above, along with the rising focus of prominent players on R&D activities to develop novel products, are anticipated to boost the adoption rate, thereby contributing to the global laser capture microdissection market growth.

Other Prominent Drivers

• Increasing use in single-cell analysis workflows and spatial transcriptomics that require accurate isolation of cells/tissues.

Market Restraints

High Cost Associated with Advanced Products to Limit Market Growth

There is an increasing focus on tissue-based research among researchers to address the growing prevalence of cancer and other chronic conditions. However, the high capital and operational costs associated with these advanced devices are expected to hamper the adoption rate for these systems, particularly in developing countries, including India, Mexico, and others.

The advanced LCM devices, including ultraviolet, immunofluorescence-based, and other systems, require expensive precision optics, laser modules, high-resolution imaging units, and specialized software, which contributes to the high capital investment. Additionally, laser replacement, consumables, and maintenance services further add to the financial burden.

• For instance, according to several articles published by the National Center for Biotechnology Information (NCBI), it was reported that the cost of laser capture microdissection (LCM) instruments is about USD 150,000 to 350,000.

Market Opportunities

Increasing Cancer Research Funding to Create Market Opportunity

There is an increasing focus on investments in cancer research and precision medicine worldwide. Healthcare facilities, governmental organizations, and prominent companies are increasing funding for translational science, oncology research, and biomarker discovery, resulting in the growing adoption of cell and tissue isolation tools, such as LCM, among laboratories.

Moreover, the growing research funding is expanding the R&D capacity in spatial pathology, transcriptomics, genomics, and other areas, further boosting the demand for LCM tools in the market. This, along with, growing focus of major players toward integration of artificial intelligence and machine learning in these devices, is anticipated to boost the investment in the global laser microdissection market.

• According to data published by the National Cancer Institute (NCI), research funding for breast cancer increased from USD 514.6 million in 2020 to USD 542.0 million in 2023.

Market Challenges

Limited Healthcare Access in Developing Countries to Hinder Market Growth

There is an increasing emphasis on novel LCM tools for tissue-based research among researchers. However, limited healthcare expenditure, shortage of skilled professionals, coupled with inadequate reimbursement policies, especially in emerging nations, are some of the factors resulting in limited access to clinical facilities among patients.

Furthermore, a limited number of healthcare settings, such as molecular diagnostic centers, pathology labs, and others, is also resulting in the delayed detection of various forms of cancer, resulting in the postponement of diagnostic procedures among patients, especially in developing countries, such as China and Brazil, among others.

• For instance, according to 2025 data published by the National Center for Biotechnology Information (NCBI), it was reported that about 47% of the global population lacks access to basic diagnostics for many common diseases.

Other Prominent Challenges

• Competition from alternative microdissection and cell-isolation technologies (e.g., microfluidics, laser capture alternatives).
• Consumable costs and validation requirements for clinical applications are restricting rapid clinical uptake.

Laser Capture Microdissection Market Trends

Technological Advancements in these Devices to Create Market Opportunities

There is an increasing demand for automated and precision devices in molecular biology, oncology research, and translational medicine, which is driving a preferential shift toward advanced systems. Technological advancements in these devices improve consistency in cell boundary recognition, laser-cutting precision, and tissue identification, supporting the demand for these products in the market.

The integration of artificial intelligence, robotic stages, multi-laser modules, and other advanced features in these systems has accelerated and improved clinical outcomes and workflow efficiency. This, along with the increasing focus of prominent players on R&D activities to launch technologically advanced products, is anticipated to boost the adoption rate for these systems in the market.

• In April 2025, Laxco, Inc., launched Accuva LEAP, Laxco Expandable Advanced Platform, an imaging system designed to support scientific research.

Other Prominent Trends

• Integration of LCM with next-generation sequencing, proteomics, and spatial biology platforms to enable targeted molecular profiling.
• Growing demand for ready-to-use consumables, specialty slides, and kits tailored for specific tissue types.
• Expansion of service-model offerings (LCM-as-a-service) from contract research organizations and core facilities.
• Increased focus on user-friendly software for image-guided dissection and data traceability.

Download Free sample to learn more about this report.

SEGMENTATION ANALYSIS

By Type

Growing Product Launches to Boost Hardware Segment Dominance

Based on type, the market is classified into hardware and software & services. Hardware is further bifurcated into instruments and consumables. Additionally, instruments are further divided into ultraviolet LCM, infrared LCM, immunofluorescence LCM, and others.

The hardware segment accounted for the largest market share in 2025. The growth is due to the increasing prevalence of cancer among the patient population, resulting in a rising demand for advanced LCM products globally. This, coupled with the rising focus of key market players toward research and development activities to launch novel products, is further anticipated to support the segmental growth.

• In March 2020, Fluidigm Corporation introduced the AccuLift Laser Capture Microdissection System for translational and clinical pathology research.

The software & services segment is expected to grow at a CAGR of 8.1% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Application

Increasing R&D Spending Led to Dominance of Research & Development Segment

Based on application, the market is segmented into research & development, diagnostics, and others.

The research & development segment dominated the global market in 2025. By application, the research & development segment held the share of 57.7% in 2025. The growth is primarily due to the growing prevalence of various types of cancer, further resulting in a rising research and development spending among the pharmaceutical and biotechnological companies for tissue-based research across the globe.

• For instance, according to the 2023 data published by PatentPC, it was reported that the biotech industry is investing heavily in research, with R&D spending hitting an estimated $250 billion in 2023.

The segment of diagnostics is set to flourish with a growth rate of 7.6% across the forecast period.

By End-user

Increasing Number of Pharmaceutical & Biotechnological Companies Led to Segment’s Dominance

Based on end user, the market is segmented into hospitals & clinics, clinical laboratories, pharmaceutical & biotechnological companies, and others.

The pharmaceutical & biotechnological companies segment dominated the market in 2025. The increasing prevalence of various types of cancer, the growing number of pharmaceutical & biotechnological companies, and others are some of the vital factors supporting the growth of the segment in the market. Furthermore, the segment is set to hold a 31.7% share in 2026.

• For instance, according to 2025 statistics published by the Cross River Therapy, there are over 5,000 pharmaceutical & biotechnological companies in the U.S.

In addition, clinical laboratories’ end users are projected to grow at a CAGR of 7.8% during the study period.

Laser Capture Microdissection Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held the dominant share in 2024, valued at USD 114.8 million, and also took the leading share in 2025 with USD 122.8 million. The dominance of the region is owing to certain factors, such as the increasing research expenditure, growing prevalence of cancer, leading academic and pharma research centers, and early technology adoption. In 2025, the U.S. market is estimated to reach USD 112.3 million.

• For instance, according to 2022 statistics published by the World Cancer Research Fund (WCRF), it was reported that about 230,125 people were suffering from prostate cancer in the U.S.

Europe and Asia Pacific

Europe and the Asia Pacific are expected to witness considerable growth in the forecast period. During the study period, the European region is projected to record a growth rate of 5.9% and reach a valuation of USD 69.8 million in 2026. This is due to the strong translational research activity and growing clinical research adoption in the region. Additionally, rising research investments, expanding biotech/pharma sectors in China, Japan, South Korea, and India are also contributing factors to market growth. Backed by these factors, countries such as the U.K. are expected to record the valuation of USD 7.9 million, Germany to record USD 11.4 million, and France to record USD 7.5 million in 2025. After Europe, the market in the Asia Pacific is estimated to reach USD 78.1 million in 2026 and secure the position of the third-largest region in the market. In the region, India is estimated to reach USD 8.5 million while China is estimated to reach USD 23.1 million in 2026.

Latin America and Middle East & Africa

Over the forecast period, Latin America and the Middle East & Africa regions are expected to witness moderate growth in this market. The Latin America market in 2025 is set to record USD 0.25 billion as its valuation. The emerging markets with gradual uptake are linked to the development of research infrastructure and collaborative projects in these regions, which are expected to support the growth of the regions in the market. In the Middle East & Africa, GCC is set to attain the value of USD 3.8 million in 2026.

Competitive Landscape

Key Industry Players

Increasing Number of Product Launches Among Prominent Players to Support Their Dominance

A robust & diversified product portfolio of advanced systems, along with a strong geographic presence, is one of the prominent factors contributing to the dominance of these companies in the market. In 2025, Thermo Fisher Scientific Inc. and Danaher Corporation are prominent players in the market. Moreover, the increasing focus of prominent players on product launches is mostly to support the global laser capture microdissection market share.

• For instance, in March 2019, Thermo Fisher Scientific Inc., introduced the Arcturus Cellect Laser Capture Microdissection (LCM) System, a redesigned LCM instrument with an aim to strengthen its product portfolio.

However, key players, including Leica Microsystems, and others, are also growing in the market, primarily due to their increasing focus on acquisitions and collaborations to strengthen their presence in the market.

List of Key Laser Capture Microdissection Companies Profiled

• Thermo Fisher Scientific Inc. (U.S.)
• Targeted Bioscience (U.S.)
• Laxco, Inc. (U.S.)
• Carl Zeiss AG (Germany)
• Molecular Machines and Industries GmbH (Germany)
• Danaher Corporation (U.S.)
• Standard BioTools Inc. (U.S.)
• CaresBio Laboratory (U.S.)
• AnaPath Services GmbH (Germany)
• Creative Bioarray (U.S.)

KEY INDUSTRY DEVELOPMENTS

• October 2025: Thermo Fisher Scientific Inc., expanded the Research and Development Centre of Excellence in India. This helped the company in strengthening its global presence.
• April 2025: Dr. Lal Pathlabs introduced Amyloid Typing by laser capture microdissection and mass spectrometry for the identification of Amyloid proteins with an aim to widen its service offerings.
• April 2024: Molecular Machines & Industries GmbH launched the CellCut high-precision laser microdissection system, which enables the dissection of tissue areas, single cells, and subcellular structures with accuracy, with an aim to strengthen its presence in the market.
• November 2023: Laxco, Inc., launched the Accuva Cellect Laser Capture Microdissection (LCM) System to strengthen its product portfolio.
• August 2023: Thermo Fisher Scientific Inc., partnered with Laxco Inc., to commercialize the Arcturus Cellect LCM system to increase its brand presence.

REPORT COVERAGE

The market report provides a detailed global laser capture microdissection market analysis and focuses on key aspects such as leading companies, type, application, and end user. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation